Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.71 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.66 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.62 |
| ▸ | FAAH | O00519 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13730236 | 1.00 | ACE2 (0.71) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL8586725 | 1.00 | ACE2 (0.71) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL12092729 | 0.96 | ACE2 (0.66) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL545070 | 0.94 | ACE2 (0.80) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL7146627 | 0.94 | ACE2 (0.80) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL2054033 | 0.94 | ACE2 (0.80) | ACE2FFAR1FFAR4GPR84FAAH | |
| Dodecane SCHEMBL14691319 | 0.94 | ACE2 (0.80) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL277986 | 0.94 | ACE2 (0.80) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL7080552 | 0.94 | ACE2 (0.80) | ACE2FFAR1FFAR4GPR84FAAH | |
| SCHEMBL247871 | 0.94 | ACE2 (0.80) | ACE2FFAR1FFAR4GPR84FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120079257-A | Asymmetric PMP hollow fiber membrane for blood oxygenation and preparation method and application thereof | 杭州费尔新材料有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120079256-A | Asymmetric PMP hollow fiber oxygenation membrane and preparation method and application thereof | 杭州费尔新材料有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-114733366-B | Preparation method of asymmetric hollow fiber membrane | 杭州费尔新材料有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-111346519-B | Preparation method of asymmetric polyolefin film | 杭州科百特过滤器材有限公司 | 2023-11-24 | — | — | CN | claimed |
| US-20230302411-A1 | ASYMMETRIC HYDROPHOBIC POLYOLEFIN HOLLOW FIBER MEMBRANE, PREPARING METHOD, AND USE OF THE SAME | HANGZHOU COBETTER TECHNOLOGY CO., LTD. (CN) | 2023-09-28 | — | — | US | claimed |
| CN-111888946-B | Asymmetric hydrophobic polyolefin hollow fiber membrane for blood oxygenation and preparation method and application thereof | 杭州科百特科技有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-114733365-A | Preparation process of polyolefin hollow fiber membrane | 杭州费尔新材料有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114733360-A | Preparation method of polyolefin hollow fiber membrane | 杭州费尔新材料有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114733366-A | Preparation method of asymmetric hollow fiber membrane | 杭州费尔新材料有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-111888946-A | Asymmetric hydrophobic polyolefin hollow fiber membrane and preparation method and application thereof | 杭州科百特科技有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-111346519-A | Preparation method of asymmetric polyolefin film | 杭州科百特过滤器材有限公司 | 2020-06-30 | — | — | CN | claimed |
| CN-110548411-A | Preparation method of asymmetric polyolefin film | HANGZHOU COBETTER FILTRATION EQUIPMENT CO LTD | 2019-12-10 | — | — | CN | claimed |
| CN-110538582-A | Preparation method of asymmetric polyolefin film | HANGZHOU COBETTER FILTRATION EQUIPMENT CO LTD | 2019-12-06 | — | — | CN | claimed |
| US-20190016984-A1 | CONTINUOUS PROCESS FOR THE MANUFACTURE OF GREASE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2019-01-17 | — | — | US | claimed |
| WO-2019014092-A1 | CONTINUOUS PROCESS FOR THE MANUFACTURE OF GREASE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-01-17 | — | — | WO | claimed |
| US-7829512-B2 | Method and equipment for making a complex lithium grease | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2010-11-09 | — | — | US | claimed |
| WO-2005037426-A1 | CONICAL GAS / LIQUID SEPARATOR WITH A STIRRER FOR MAKING A GREASE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2005-04-28 | — | — | WO | claimed |
| US-20050082014-A1 | Method and equipment for making a complex lithium grease | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2005-04-21 | — | — | US | claimed |
| US-20040223987-A1 | Composition structured with a polymer containing a heteroatom and organogelator | L'OREAL S.A. (FR) | 2004-11-11 | — | — | US | claimed |
| WO-2002047628-A1 | COMPOSITION STRUCTURED WITH A POLYMER CONTAINING A HETEROATOM AND AN ORGANOGELATOR | L'ORÉAL (FR) | 2002-06-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223987-A1 | Composition structured with a polymer containing a heteroatom and organogelator | CUTA, PARG, FABP4 | ACE2 4347/4885FFAR1 161/4885FFAR4 386/4885 |
| US-20190016984-A1 | CONTINUOUS PROCESS FOR THE MANUFACTURE OF GREASE | FASN, SCD, ELOVL1 | ACE2 3173/4885FFAR1 272/4885FFAR4 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.